Where I see patients (1)
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment.
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice.
Smell the roses